ArticleBMJ open2024

Efficacy and safety of henagliflozin combined with continuous subcutaneous insulin infusion in the treatment of Chinese inpatients with type 2 diabetes mellitus based on a continuous glucose monitoring system: protocol of a multicentre, open-label, inpatient, randomised, controlled trial.

Yingling Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.